Synendos Therapeutics CHF 20m Series A Financing: the advisor

Walder Wyss advised the investors co-led by Kurma Partners and Sunstone Life Science Ventures on the CHF 20m series A financing of Synendos Therapeutics.

The team included Alexander Gutmans (Partner, Corporate/M&A and Venture Capital – pictured), Robert von Rosen (Partner, Corporate/M&A and Venture Capital) and Karina Tschon (Associate, Corporate/M&A and Venture Capital).